| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07222215 | PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer… | Estrogen-receptor-positive Breast Cancer | Recruiting |
| Phase 1/2 | |||
| NCT07198724 | ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients… | Metastatic Breast Cancer | Recruiting |